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Objective: In patients with ischemic cardiomyopathy and substantial amounts of
dysfunctional but viable myocardium, revascularization cannot always improve the
left ventricular ejection fraction. We sought to investigate the interaction between
the left ventricular volume and the amount of viable myocardium to predict the left
ventricular ejection fraction increase after revascularization.
Methods: Eighty-five consecutive patients with a depressed left ventricular ejection
fraction (mean: 27.3%6 5.2%) underwent coronary artery bypass grafting after a do-
butamine stress echocardiography had determined that they had at least 4 viable seg-
ments. Six months after coronary artery bypass grafting, left ventricular ejection
fraction and regional wall motion were reassessed.
Results: Although the left ventricular ejection fraction was expected to recover more
than 5% in all 85 patients after coronary artery bypass grafting, it did not improve in
15 patients (17.6%) despite the presence of viable segments. The likelihood of the left
ventricular ejection fraction recovery decreased proportionally with an increase in the
left ventricular end-systolic volume. The nonimprovers had a higher left ventricular
end-systolic volume (164.26 22.4 mL vs 125.66 23.4 mL, P5 .0001). In addition,
the number of viable segments during the dobutamine stress echocardiography had
a significant correlation with the ejection fraction increase after 6 months (P ,
.0001). Patients with 6 viable segments showed a good outcome irrespective of their
left ventricular end-systolic volume. In patients with fewer than 6 viable segments, left
ventricular end-systolic volume was a major factor in the prognosis: Patients with left
ventricular end-systolic volume of 145 or more had a poor left ventricular ejection
fraction increase and vice versa.
Conclusion: The extent of left ventricular remodeling determines the rate of functional
improvement after coronary artery bypass grafting. Patients with a high left ventric-
ular end-systolic volume and fewer than 6 viable segments have a lower likelihood
of improvement.
M
yocardial revascularization in patients with severe ischemic left ventricular
(LV) dysfunction remains controversial because of concerns over
operative mortality and morbidity and a lack of functional and survival
benefits.1 Nevertheless, because medical treatment alone has a poor outlook, revas-
cularization or cardiac transplantation may be considered for patients with ischemic
cardiomyopathy.2,3
Operative mortality and early mortality (during a 30-day period after surgery) have
been reported to be higher in patients with a low ejection fraction (EF),4,5 and there
seems to be a virtually linear increase in risk with the decreasing values of left
ventricular ejection fraction (LVEF).5 The mortality rate at 1 year, however, is
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CABG 5 coronary artery bypass grafting
DSE 5 dobutamine stress echocardiography
EF 5 ejection fraction
LV 5 left ventricular
LVEDV 5 left ventricular end-diastolic volume
LVEF 5 left ventricular ejection fraction
LVESV 5 left ventricular end-systolic volume
LVESVI 5 left ventricular end-systolic volume index
significantly lower in patients with low EF who have under-
gone coronary artery bypass grafting (CABG) than that of
nonrevascularized patients with low EF.4
CABG can be performed relatively safely in low EF cases,
yielding an acceptable perioperative mortality risk and im-
provement in functional status, quality of life, and LV func-
tion (documented by a significant decrease in systolic LV
dimensions and increase in EF).1,4,6,7
CABG is indicated in selected patients with ischemic
cardiomyopathy. CABG may be offered to patients with
impaired ventricular function; however, before opting for
surgery, a rigorous patient selection and management re-
quires the consideration of potentially reversible dysfunction
(the presence of viable myocardium is necessary).1,8
It is important to recognize hibernating myocardium in
patients with ischemic cardiomyopathy because symptoms
resulting from chronic LV dysfunction may be due to a re-
versible ischemic process.9 It has emerged that approxi-
mately 50% of patients with ischemic cardiomyopathy
have a substantial amount of hibernating myocardium.10,11
Myocardial contractility in viable myocardium can be re-
versible after revascularization. In patients with a consider-
able amount of viable myocardium, the failure to recover
may be related to an increased LV volume in the wake of ex-
tensive ventricular remodeling.10,12,13
In this study, we investigated the effects of some preoper-
ative factors, left ventricular end-systolic volume (LVESV),
and the number of viable segments on LV function after re-
vascularization in patients with ischemic cardiomyopathy.
In addition, to facilitate the decision-making process for the
suitable surgical procedure, we looked into the interaction
of these factors to exactly predict which patients would
show LV function improvement after CABG alone and
which patients would not and, therefore, might need an addi-
tional procedure.
Patients and Methods
Study Population and Protocol
BetweenMay of 2003 and April of 2004, 85 patients (63 men and 22
women) with a mean age of 59.56 13.8 years (range: 30–81 years)
were studied. All subjects had symptomatic ischemic heart disease
with a severely depressed LVEF (#35%) due to chronic coronaryThe Journal of Thorartery disease, which was confirmed by angiography. The patients
underwent CABG under cardiopulmonary bypass according to their
clinical status and coronary angiography.
Patients with primary cardiomyopathy, significant valvular heart
disease (including ischemic mitral regurgitation), concomitant valve
surgery, and LV aneurysm requiring repair were excluded from this
study.
The study protocol was as follows: Regional wall-motion abnor-
mality, LV volumes, and myocardial viability of the subjects were
evaluated once pre-CABG via stress echocardiography and then 6
months afterward by echocardiography. Ethical approval was
granted by the hospital’s ethics committee, and written informed
consent for inclusion in the study was obtained from the patients.
Echocardiography
All patients underwent preoperative dobutamine stress echocardiog-
raphy (DSE) within 24 hours before CABG and postoperative trans-
thoracic echocardiography 6 months after surgery.
The echocardiograms were obtained with a commercially avail-
able ultrasound machine (GE Vivid 7, Horten, Norway) with a 2.0 to
3.0-MHz phased-array transducer. The images were acquired from
standard parasternal long- and short-axis planes, and from apical
4- and 2-chamber planes (in cine-loop format). All standard images
were recorded on both optical disks and videotapes.
Left ventricular end-diastolic volume (LVEDV), LVESV, and
LVEF were determined off-line by the cross-sectional biplane disk
method using a modified Simpson’s rule. The endocardial borders
of the 2- and 4-chamber apical viewswere digitally traced at end dias-
tole and end systole. An increased LVEF of 5% or more after CABG
was considered clinically significant, as described previously.10
Assessment of Myocardial Viability
Resting transthoracic echocardiography was followed by a low-dose
DSE study. The dobutamine infusion was commenced with 2.5 mg/
kg/min, which was subsequently increased to 5, 7.5, and 10 mg/kg of
body weight per minute in 3-minute stages. At each stage, the blood
pressure and heart rate were measured. The end points of the test
were significant ventricular and supraventricular arrhythmia, signif-
icant bradyarrhythmia, increased blood pressure of more than 240/
120 mm Hg, decrease of 20 mm Hg in the systolic blood pressure
compared with the baseline value, new wall-motion abnormality,
ST depression of 2 mm or more, and severe angina.
The left ventricle was divided according to the recommendations
of the American Society of Echocardiography, and a 16-segment
model was used.14 The images were displayed side by side in
a quad-screen format at any stage. Regional wall motion and systolic
wall thickening were scored using a 5-point grading scale: 15 nor-
mal; 2 5 mildly hypokinetic; 3 5 severely hypokinetic; 4 5 aki-
netic; and 5 5 dyskinetic. Segments with severe hypokinesia,
akinesia, or dyskinesia were considered abnormal and evaluated
for viability. Segments with improvement in wall-motion response
were considered viable, and dysfunctional segments without change
in contractility were considered nonviable.
Statistical Analysis
Data analyses were performed using the Statistical Package for the
Social Sciences version 11.0 statistical analysis software (SPSS
Inc, Chicago, Ill). Data were presented as mean 6 standard devia-
tion for continuous variables and as numbers (%) for categoricacic and Cardiovascular Surgery c Volume 136, Number 4 931
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goric comparisons between the groups, and the Student t test or anal-
ysis of variance was used for continuous measurements. Pearson’s
correlation coefficient was applied to show the correlation between
the 2 continuous variables.
Linear regression enabled us to assess the independence of the
factors related to the EF increase after 6 months. All independent
variables were entered into the model, and the variables with a P
value greater than .1 were exited. For the model’s goodness of fit,
the R2 was presented.
The patients with considerable amounts of myocardial viability
were divided into 2 groups: those with and without improvement
in the LV function after revascularization (an LVEF increase of $
5% and an LVEF increase of , 5%, respectively).
Results
Patient Characteristics
The clinical and echocardiographic characteristics of the
study population are presented in Table 1. Eighty-five
patients, consisting of 63 men (74.1%) and 22 women
(25.9%) with a mean age of 59.56 13.8 years, with ischemic
cardiomyopathy and substantial viability were studied. All
patients had heart failure symptoms with an average New
York Heart Association functional class of 2.8 6 0.7. The
range of preoperative EF was 20% to 35% with a mean EF
of 27.2% 6 5.3%. The mean LVESV was 132.4 6 27.4.
The number of stenosed arteries was 2.66 0.6. Perioperative
myocardial infarction, documented with cardiac enzyme in-
creasing, was not detected in the patients. An inotropic infu-
sion was used in 31 patients (36.5%) postoperatively. Eleven
patients (12.9%) required intra-aortic balloon pumps. Ven-
tricular assist devices were not used in the patients.
Contractility and Viability Status
A total of 1360 segments were evaluated with 2-dimensional
echocardiography. There were 565 segments (41.5%) with
normal contractility and 795 segments (58.5%) with abnor-
mal contractility, that is, severe hypokinesia, akinesia, and
dyskinesia.
TABLE 1. Patient characteristics
Clinical features
Age (y) 59.5 6 13.8
Male 63 (74.1%)
Previous infarction 73 (85.9%)
No. of stenosed arteries 2.6 6 0.6
NYHA functional class 2.8 6 0.7
Baseline LVEF 27.2% 6 5.3%
No. of normal segments 6.6 6 1.4
LVESV (mL) 132.4 6 27.4
NYHA, New York Heart Association; LVEF, left ventricular ejection fraction;
LVESV, left ventricular end-systolic volume. Data are presented as mean6
standard deviation or as numbers (%).932 The Journal of Thoracic and Cardiovascular Surgery c OctoDSE was only performed before CABG. The dysfunc-
tional segments were composed of 426 (53.6%) viable seg-
ments (because of functional improvement during DSE)
and 369 (46.4%) nonviable segments. After the dobutamine
infusion, the mean EF increase was 12.1% 6 3.6%, with
a minimum increase of 5%. Although post-CABG recovery
in the LV function (increase of $ 5% in EF) was expected
in those with substantial viability, LVEF improved in only
70 patients (82.4%). In 15 patients (17.6%), LVEF failed to
improve despite the presence of considerable amounts of
viability. In the total study population, the average postoper-
ative improvement in LVEF was 9.9% 6 5.9%.
Pearson’s correlation coefficient for the EF increase after 6
months and the number of the viable segments during the
DSE test was R 5 0.51 (P , .0001); the same coefficient
for the correlation between the EF increase after 6 months
and the number of the recovered segments after 6 months
was R 5 0.84 (P , .0001).
Comparison Between Left Ventricular Function
Improvers and Nonimprovers
Table 2 shows a comparison between the LV function im-
provers and nonimprovers. The clinical characteristics and
echocardiographic datawere comparable between the 2 groups
(LVEF increase$ 5%andLVEF increase, 5%).Weobtained
data independently of LVESV, which was different in the 2
groups. The nonimprovers had a significantly larger LVESV
than the improvers (164.2 6 22.4 mL vs 125.6 6 23.4 mL,
respectively; P 5 .0001). The average numbers of stenosed
coronary arteries in the LV function improvers and nonim-
provers were 2.56 0.6 and 2.86 0.4, respectively (P5 .047).
In the univariate analysis, the number of stenosed arteries,
baseline LVEF, number of normal segments at rest, number
TABLE 2. Comparison between patients with substantial






N 5 15 P
Age (y) 59.2 6 15.1 60.5 6 2.9 .510
Male gender 53 (75.7%) 10 (66.7%) .468
Previous infarction 60 (85.7%) 13 (92.9%) .470
No. of stenosed arteries 2.53 6 0.63 2.80 6 0.41 .047
No. of grafts 3.69 6 1.12 3.73 6 1.10 .882
NYHA functional class 2.80 6 0.73 2.80 6 0.68 1.000
Baseline LVEF 27.9% 6 5.5% 23.9% 6 2.7% .000
No. of normal segments 6.8 6 1.5 6.0 6 0.0 .000
LVESV (mL) 125.6 6 23.4 164.2 6 22.4 .000
No. of viable segments
during DSE
5.2 6 0.8 4.3 6 0.5 .000
NYHA, New York Heart Association; LVEF, left ventricular ejection fraction;
LVESV, left ventricular end-systolic volume; DSE, dobutamine stress echo-
cardiography.ber 2008
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Unstandardized coefficients Standardized coefficients
B SE Beta t P
(Constant) 84.022 11.295 7.439 .000
Age 20.129 0.025 20.300 25.212 .000
LVESV 20.622 0.086 22.887 27.235 .000
No. of viable segments during DSE 210.953 2.343 21.580 24.675 .000
No. of viable segments during DSE * LVESV 0.107 0.018 3.043 6.110 .000
SE, Standard error; LVESV, left ventricular end-systolic volume; DSE, dobutamine stress echocardiography. Number of viable segments during DSE * LVESV.
Interaction between the number of viable segments during DSE and LVESV. R2 5 0.75.A
CDof the viable segments during DSE, and LVESV were differ-
ent between the 2 groups. In the regression model, however,
only age, LVESV, the number of viable segments during
DSE, and the interaction between the 2 variables of LVESV
and the number of viable segments during DSE had a signif-
icant correlation with the increase in EF (Table 3).
As we mentioned, there was an interaction between
LVESV and the number of viable segments during DSE;
we assessed the mean of the EF increase at different numbers
of viable segments during the DSE study in 2 levels of
LVESV (,145 and $145 mL) (Figure 1). The existence of
6 or more viable segments discovered during DSE was pre-
dictive of a good surgical outcome despite a large LVESV.
On the other hand, when there were fewer than 6 viable seg-
ments detected via the DSE study, LVESV played a major
role in the outcome prediction: Patients with LVESV less
than 145 mL improved, whereas patients with LVESV of
145 mL or more did not.
Discussion
Surgical revascularization in patients with a severe impair-
ment of the LV function yields more favorable outcomes if
patient selection and management are performed thoroughly.
Figure 1. The amount of the LVEF increase based on the number of
viable segments during preoperative DSE in different LVESV
groups. LVESV, Left ventricular end-systolic volume; DSE, dobut-
amine stress echocardiography; LVEF, left ventricular ejection
fraction.The Journal of ThorIt has been posited that an accurate prediction of the post-
operative functional recovery in patients with ischemic car-
diomyopathy and a mixture of viable and nonviable tissues
requires the consideration of the number of both viable and
nonviable (scar) segments.15
After revascularization, improvement in LV function and
prognosis is expected in patients with considerable amounts
of myocardial viability. Nonetheless, many patients with
substantial viability in their dysfunctional myocardium do
not exhibit such functional improvement, which could be
explained by the increased LV volume after extensive ven-
tricular remodeling.12,13
The present study evaluated 85 patients with substantial
viability ($4 viable segments) once pre-CABG and then 6
months post-CABG. Despite substantial viability and expec-
tation of improvement in the global function after surgery, the
LV function failed to recover in 15 (17.6%) of our subjects.
A subsequent comparison between the LVEF improvers
and nonimprovers produced the following results: Baseline
LVEF, number of stenosed arteries, number of normal seg-
ments before CABG, LVESV, and number of viable seg-
ments during DSE were significantly different between the
2 groups. With Pearson’s correlation coefficient, however,
only age, LVESV, and number of viable segments during
DSE were found to have a significant correlation with the
LVEF increase after CABG.
In patients undergoing CABG, the operative mortality and
morbidity are higher in patients with severe LV dysfunction
and substantial viable myocardium than in those with a nor-
mal LV function. Although a low EF is the major risk factor
for operative mortality, EF alone may not necessarily be an
accurate predictor of operative mortality.16 Kawachi and col-
leagues16 assessed the correlations between a large left ven-
tricle with LV dysfunction and operative mortality in 106
patients with an EF of 40% or less. In their study, the hospital
mortality in the patients with an EF less than 40% and an
LVESV of 140 mL/m2 or more was 50%; and the hospital
mortality in the patients with an LVEDV of 200 mL/m2 or
more was 67%. The authors did not evaluate the LVEF im-
provement after revascularization. They concluded that pa-
tients with a low EF and an elevated LVESV or LVEDV
were at increased risk for hospital death after CABG.16acic and Cardiovascular Surgery c Volume 136, Number 4 933
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176 patients with an LVEF of less than 30% who underwent
isolated CABG. Having evaluated predictors of survival and
early outcome after coronary artery surgery, they posited that
the left ventricular end-systolic volume index (LVESVI) was
the only independent parameter of the LV function predictive
of survival. They also did not assess the LVEF improvement
after revascularization.
Yamaguchi and colleagues12 demonstrated that the mean
EF improved significantly after CABG in patients with a pre-
operative LVESVI of less than 100 mL/m2 despite the pres-
ence of a global LVEF of less than 30%. They determined the
preoperative and postoperative EF, LVESVI, and LVEDV
index by using biplane left cineventriculography. However,
they chose not to assess viability. Another study demon-
strated that the improvement in LVEF was more prominent
in patients with a preoperative LV end-diastolic diameter of
less than 70 mm.8
Rizzello and colleagues18 evaluated the probability of the
LV functional recovery after CABG via resting 2-dimen-
sional echocardiography; they did not make use of DSE in
their study. The cutoff value of an end-diastolic volume index
of 90 mL or more accurately identified patients who would
virtually never recover. It was concluded that patients with is-
chemic cardiomyopathy and severe LV enlargement were
unlikely to exhibit improvement in LVEF after revasculariza-
tion. Conversely, patients with a relatively preserved LV size
had a higher likelihood of functional recovery.
Bax and colleagues19 evaluated recovery in the LV func-
tion after CABG and long-term prognosis in patients with ex-
tensive LV remodeling. LVESV was the only parameter that
was significantly different between the groups (1096 46 mL
for the improvers vs 1416 31mL for the nonimprovers). The
change in LVEF after revascularization was linearly related
to the baseline LVESV: The higher the LVESV, the lower
the likelihood of improvement in LVEF after revasculariza-
tion. Viability was assessed by means of metabolic imaging
with F18-fluorodeoxyglucose and single photon emission
computed tomography. During a 3-year follow-up period,
the highest event rate (67%) was observed in patients without
viable myocardium and a large LV size, whereas the lowest
event rate (5%) was observed in patients with viable myocar-
dium and a small LV size. The authors concluded that exten-
sive LV remodeling not only prohibited improvement in
LVEF after revascularization but also affected long-term
prognosis negatively despite considerable viability.
Schinkel and colleagues10 studied 118 patients (61 pa-
tients had substantial viability) with an average LVEF of
29% due to chronic coronary artery disease. The subjects un-
derwent revascularization, and DSE and radionuclide ventri-
culography were used for the assessment of viability and
determination of LVEF, respectively. LVEF did not improve
in 33%of 61 patients despite substantial viability. The nonim-
provers had a considerably larger LVESV (153 6 41 mL vs934 The Journal of Thoracic and Cardiovascular Surgery c Oct133 6 46 mL). The likelihood of the recovery of the global
function decreased proportionally with the increase in
LVESV. The researchers demonstrated that an LVESV of
140 mL or more had the highest sensitivity and specificity
for the prediction of the absence of the global recovery.
It can be concluded that the existence of viability in the
dysfunctional tissue, albeit essential, is not sufficient for
post-CABG LVEF improvement and that some other factors
must exert a significant influence. Usually a value of 4 or
more viable segments is advised as a cutoff value for the pre-
diction of the LVEF improvement.20,21 The presence of this
level of viability (25% of LV mass) predicts patients who
may benefit from revascularization.20,21 Because revascular-
ization alone cannot improve LVEF in patients with an in-
creased LVESV even if there is substantial viability (ie, $
4 viable segments), not only the presence of myocardial via-
bility but also the cardiac remodeling and enlargement of the
left ventricle should be taken into consideration. This may be
helpful in case selection before CABG: Patients with an in-
creased LVESV as a result of extensive cardiac remodeling
may require more viable segments to ensure a good post-
CABG prognosis. On the other hand, in the present study
a significant correlation was found between the number of vi-
able segments during preoperative DSE and the EF increase
after CABG, and patients with 6 or more viable segments
showed an encouraging post-CABG outcome. Our findings
in this study agree with those of previous studies.22
In addition to some known predicting factors (eg, LVESV
and LVEDV) reflecting the severity of cardiac remodeling,
some other factors (eg, number of viable segments during
preoperative DSE) should be drawn on to predict who may
benefit from revascularization. Considering both the severity
of cardiac remodeling and the number of viable segments
during preoperative DSE must be superior to taking into ac-
count either alone. Although the above-mentioned studies
have accurately described the cutoff values for LVESV and
the amount of viability, to our knowledge none have evalu-
ated the interaction between these predicting factors. We,
however, used the 2 predicting factors of LVESV and the
number of viable segments to make a prognosis in patients
with ischemic cardiomyopathy scheduled for CABG. As de-
picted in Figure 1, the postoperative functional recovery was
encouraging in patients who had 6 viable segments. In the
other patients with fewer than 6 viable segments, LVESV
played a key role. Moreover, the patients with an LVESV
of less than 145 mL showed an acceptable outcome, whereas
patients with an LVESV of 145 mL or more did not improve.
An increased LVESV inhibits the functional recovery af-
ter CABG in patients without a large mass of viable segments
(6 viable segments). In these patients with an enlarged left
ventricle, CABG should be combined with LV restoration
to improve outcomes compared with CABG alone even in
the absence of aneurysm. LV restoration affords significant
improvement in EF in comparison with CABG alone withoutober 2008
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segments may reduce wall stress and break the vicious cycle
of cardiac remodeling and consequently improve the LV ge-
ometry and function in selected patients.23,24More important,
LV restoration reduces late morbidity and mortality com-
pared with CABG alone in patients with large ventricles.25
Future studies are necessary to identify how to approach
the patients with substantial dysfunctional but viable myocar-
dium accompanied by extensive LV enlargement.
Study Limitations
All of the significantly stenosed vessels were subjected to
complete revascularization. Post-CABG follow-up coronary
angiography was not performed; therefore, it can be argued
that the presence of graft occlusion is likely to have precluded
improvement in the LV function. In addition, the drugs used
for the treatment of heart failure and ischemic heart disease
(eg, beta-blockers and angiotensin-converting enzyme inhib-
itors) may have affected the LV function.
Our results were obtained over a 6-month period. Need-
less to say, a longer period of time may have yielded better
results in LV function improvement. The small sample size
and the resultant limitations in the multivariate statistical
analysis in this study call for further research with a more
extended scope.
Conclusions
In patients with ischemic cardiomyopathy accompanied by
fewer than 6 viable segments during a preoperative DSE
study, the extent of LV remodeling and dilatation is impor-
tant in making an accurate prediction of the LV function im-
provement after coronary revascularization. An increased
LVESV in the wake of extensive LV remodeling reduces
the likelihood of improvement in the global function; there-
fore, another surgical procedure may be required to improve
the LV function in this group of patients. On the other hand,
in patients with a large mass of viable myocardium (ie, 6 vi-
able segments) CABG has a favorable outcome irrespective
of LVESV.
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